Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Continuous Subcutaneous Insulin: Is there a role in type 2 dabetes?

Best Practice Series in Diabetes - Type 2

Zachary Bloomgarden, MD, Editor of The Journal of Diabetes and Clinical Professor in the Dept. of Medicine at the Mount Sinai School of Medicine, discusses the optimal use of insulin in treatment for diabetes.

Disclosures:
Speaker’s Bureau: Merck, NovoNordisk, GSK
Advisory Panel: Merck, BMS, Astra Zeneca, Boehringer Ingelheim, Biodel
Consultant: Merck, Novartis, Dainippon Sumitomo Pharma America, Forest Laboratories
Stock/Shareholder: Covidien, Bard, Novartis, Roche, Stryker